 |
cannabidiol |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-23 00:00:00 |
| Sponsor | Zynerba Pharmaceuticals, Inc.;80 West Lancaster Avenue, Suite 300;Devon, Pennsylvania, 19333 |
| |
cannabidiol |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-23 00:00:00 |
| Sponsor | Zynerba Pharmaceuticals, Inc.;80 West Lancaster Avenue, Suite 300;Devon, Pennsylvania, 19333 |